scispace - formally typeset
S

Sejal R. Ranmal

Researcher at University College London

Publications -  13
Citations -  564

Sejal R. Ranmal is an academic researcher from University College London. The author has contributed to research in topics: Clostridium difficile & Palatability. The author has an hindex of 9, co-authored 12 publications receiving 404 citations.

Papers
More filters
Journal ArticleDOI

Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.

TL;DR: A better understanding of the acceptability of existing formulations highlights opportunities for the development of new and more acceptable medicines and facilitates safe and effective prescribing for the young and older populations.
Journal ArticleDOI

Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations.

TL;DR: This review provides a comprehensive and up-to-date analysis of oral dosage forms considering key aspects of formulation design including dosage considerations, ease of use, tolerability and safety, manufacturing complexity, stability, supply and cost.
Journal ArticleDOI

I Spy with My Little Eye: A Paediatric Visual Preferences Survey of 3D Printed Tablets.

TL;DR: This study is the first to investigate children’s perceptions of printlets, and the findings aim to provide guidance for further development of paediatric-appropriate medicines using different 3DP technologies.
Journal ArticleDOI

Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study

TL;DR: The results of this study provide some evidence towards rational dosage form design, as well as methodological approaches to help design tools for further evaluation of acceptability within paediatric studies.
Journal ArticleDOI

Acceptability of orodispersible films for delivery of medicines to infants and preschool children

TL;DR: ODFs showed a high degree of acceptability among young children and their caregivers, and pharmaceutical companies should consider developing pediatric medicines in this format.